BRAK Recombinant eiwit

Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

9547

O95715

NP_004878.2

Recombinant Proteins

E. coli

Cancer, Chemokines & Cytokines, Immunology, Innate Immunity

Room Temp

The lyophilized BRAK recombinant protein is stable for at least 2 years from date of receipt at -20˚ C. Reconstituted BRAK is stable for at least 3 months when stored in working aliquots with a carrier protein at -20˚ C. As with any protein, exposing BRAK recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.

Chemokine (C-X-C motif) ligand 14

Homo sapiens

KEC, KS1, BMAC, BRAK, NJAC, MIP2G, MIP-2g, SCYB14, PSEC0212, UNQ240/PRO273, C-X-C motif chemokine 14, Chemokine BRAK

Human

20149565

Lyophilized